SHPH (STOCKS)

    Shuttle Pharmaceuticals Holdings, Inc. Common Stock

    $0.737200
    +0.037300 (+5.33%)
    Prev close: $0.699900
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Christopher Robert Cooper
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $4.12M
    Employees
    9
    P/E (TTM)
    -0.05
    P/B (TTM)
    0.63
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Dec 2025)
    Revenues -$9.52M
    Benefits Costs and Expenses -$7.12M
    Costs And Expenses $2.40M
    Nonoperating Income/Loss $195.16K
    Operating Expenses $11.92M
    Depreciation and Amortization $290.11K
    Research and Development $4.05M
    Other Operating Expenses $7.57M
    Operating Income/Loss -$11.92M
    Income/Loss From Continuing Operations After Tax -$11.72M
    Income/Loss From Continuing Operations Before Tax -$2.40M
    Net Income/Loss -$11.72M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$11.72M
    Net Income/Loss Available To Common Stockholders, Basic -$11.72M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$7.16
    Diluted Earnings Per Share -$7.16
    Basic Average Shares 1,637,926
    Diluted Average Shares 1,637,926
    Assets $10.48M
    Current Assets $502.91K
    Noncurrent Assets $9.97M
    Fixed Assets $17.32K
    Other Non-current Assets $9.96M
    Liabilities $8.22M
    Current Liabilities $7.97M
    Noncurrent Liabilities $254.64K
    Equity $2.25M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $2.25M
    Liabilities And Equity $10.48M
    Net Cash Flow From Operating Activities -$9.48M
    Net Cash Flow From Operating Activities, Continuing -$9.48M
    Net Cash Flow From Investing Activities -$3.06M
    Net Cash Flow From Investing Activities, Continuing -$3.06M
    Net Cash Flow From Financing Activities $10.95M
    Net Cash Flow From Financing Activities, Continuing $10.95M
    Net Cash Flow -$1.59M
    Net Cash Flow, Continuing -$1.59M
    Comprehensive Income/Loss -$11.72M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$11.72M
    Other Comprehensive Income/Loss $0.00